These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21991830)

  • 1. [New triple therapy in chronic hepatitis C. Increased patient chances].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Sep; 153(39):20. PubMed ID: 21991830
    [No Abstract]   [Full Text] [Related]  

  • 2. Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection.
    Flemming JA; Terrault NA
    Infect Dis Clin North Am; 2012 Dec; 26(4):903-15. PubMed ID: 23083823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
    Manns M
    MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
    [No Abstract]   [Full Text] [Related]  

  • 4. Future perspectives: towards interferon-free regimens for HCV.
    Gane E
    Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care.
    Pearlman BL
    Lancet Infect Dis; 2012 Sep; 12(9):717-28. PubMed ID: 22647717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hepatitis C infection. A revolution should not hide another].
    Sogni P
    Presse Med; 2014 Apr; 43(4 Pt 1):339-40. PubMed ID: 24661837
    [No Abstract]   [Full Text] [Related]  

  • 7. [Conclusions].
    Pineda JA
    Enferm Infecc Microbiol Clin; 2013 Jul; 31 Suppl 3():49-50. PubMed ID: 24063903
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies with boceprevir].
    MMW Fortschr Med; 2011 Jul; 153(29-31):16. PubMed ID: 21830728
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effects of interferon on chronic hepatitis C from the aspect of dosage and method of administration].
    Fukuda A
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):493-6. PubMed ID: 15359848
    [No Abstract]   [Full Text] [Related]  

  • 10. First-wave protease inhibitors for hepatitis C genotype 1 treatment: a real-life experience in Brazilian patients.
    Chachá SGF; Rodrigues JPV; Araújo RC; Pereira LRL; Villanova MG; Souza FF; Santana RC; Martinelli ALC
    Rev Soc Bras Med Trop; 2018; 51(2):146-154. PubMed ID: 29768546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of measuring HCV-RNA levels in patients with chronic hepatitis C by IFN treatment, including combination therapy with ribavirin].
    Kakumu S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):507-10. PubMed ID: 15359851
    [No Abstract]   [Full Text] [Related]  

  • 12. Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.
    Zeuzem S; Mantry P; Soriano V; Buynak RJ; Dufour JF; Pockros PJ; Wright D; Angus P; Buti M; Stern JO; Kadus W; Vinisko R; Böcher W; Mensa FJ
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):923-6. PubMed ID: 27140229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious diseases. First specific drugs raise hopes for hepatitis C.
    Enserink M
    Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of hepatitis C: new inhibitors as hammers against HCV].
    Bublak R
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():10-1. PubMed ID: 23961643
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatitis C is curable. Even slightly elevated liver enzymes need further examination].
    Niederau C
    MMW Fortschr Med; 2008 Mar; 150(13):26. PubMed ID: 18522352
    [No Abstract]   [Full Text] [Related]  

  • 16. Telaprevir for chronic HCV infection.
    van der Meer AJ; de Knegt RJ
    N Engl J Med; 2009 Jul; 361(5):533-4; author reply 534-5. PubMed ID: 19641215
    [No Abstract]   [Full Text] [Related]  

  • 17. [New times for the treatment of chronic hepatitis C].
    Gerstoft J; Fomsgaard A
    Ugeskr Laeger; 2012 Mar; 174(12):795. PubMed ID: 22433552
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of and indications for IFN retreatment of patients with chronic hepatitis C].
    Iyoda K; Kato M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):502-5. PubMed ID: 15359850
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of patients with chronic hepatitis C who have not been previously treated].
    Marcellin P; Boyer N
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B194-201. PubMed ID: 12180288
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C therapy in 2011: is less more, is more less?
    Araújo ES
    Braz J Infect Dis; 2011; 15(6):508-12. PubMed ID: 22218507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.